Plandai Biotechnology Inc (OTCMKTS:PLPL) has reported the signing of an amended deal with USN. As per news from the company, the new deal would allow PLPL to increase sales of Phytofare. Furthermore, the company also expects that this would attract a larger customer base from other distributors as well.
Plandai Biotechnology Inc (OTCMKTS:PLPL) recorded a trading volume of 24,399 shares during the September 11 session. The stock closed at a share value of $0.14 after recording gains of 2.71%, during the session.
Ritter Pharmaceuticals Inc (NASDAQ:RTTR) CEO, Michael Step, stated that his company would be present at the “3rd Microbiome R&D Business Collaboration”. He also revealed that the company would be making use of this opportunity to showcase its lead products for the treatment of lactose intolerance, once it has passed FDA approval. Furthermore, company reports suggested that the CEO would also be a part of a panel of experts at the forum. The panel would be discussing ways to encourage the growth of micro-biome therapeutics. Additionally, the panel would also focus on upcoming licensing and investment opportunities in this region as well.
Ritter Pharmaceuticals Inc (NASDAQ:RTTR) completed the September 11 session with a gain of 0.9% to its share value. The stock saw a trading of 18,877 shares to reach a close at a share price of $3.37.
Ardelyx Inc (NASDAQ:ARDX) has recently revealed an inside transaction conducted by one of the company executives, David P. Rosenbaum. The transaction was conducted on July 30, 2015, but was not disclosed to the SEC until recently on September 2, 2015. A total of 2,011 shares were sold by Mr. Rosenbaum, at a share price of $19.27. As per recent analyst reports, the company share price is estimated to fluctuate between $24 and $25. Even after the recent insider sell, the company executives still hold 43.5% of the company. However, the total insider ownership over the past year amounts to 257.09%.
Ardelyx Inc (NASDAQ:ARDX) closed at a share price of $20.84, after reporting gains of 0.92 and trading 130,480 shares during the September 11 session.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of USmarketsDaily.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: